Genet Med.2021 Jan;23(1):238. 10.1038/s41436-020-01041-5. doi: 10.1038/s41436-020-01041-5.
修正。migalastat治療を受けたFabry病患者の治療効果の臨床的モニタリングのための血漿中のlyso-Gbの評価
Correction: Assessment of plasma lyso-Gb for clinical monitoring of treatment response in migalastat-treated patients with Fabry disease.
- Daniel G Bichet
- Johannes M Aerts
- Christiane Auray-Blais
- Hiroki Maruyama
- Atul B Mehta
- Nina Skuban
- Eva Krusinska
- Raphael Schiffmann
PMID: 33219325 PMCID: PMC7790740. DOI: 10.1038/s41436-020-01041-5.
抄録
抄録はありません
